Brief: Alzinova Announces New Positive Safety Review Of Its Phase 1B Study In Alzheimer's Disease

Alzinova AB

07/09/2022 07:11

Sept 7 (Reuters) - Alzinova AB  ALZ.ST :
    * ALZINOVA ANNOUNCES NEW POSITIVE SAFETY REVIEW OF ITS PHASE
1B
STUDY IN ALZHEIMER'S DISEASE
    * SECOND EXTERNAL SAFETY REVIEW HAS BEEN CARRIED OUT OF
COMPANY'S
CLINICAL PHASE 1B STUDY - WITH A POSITIVE ASSESSMENT TO CONTINUE
STUDY AS PLANNED

Source text for Eikon:  ID:nWkr56YNBP 
Further company coverage:  ALZ.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))